A07Crizotinib in ROS1 rearranged or MET deregulated...

Annals of Oncology 2016 / 09 Vol. 27; Iss. suppl_4

A07Crizotinib in ROS1 rearranged or MET deregulated Non-Small-Cell Lung Cancer (NSCLC): Preliminary results of the METROS trial

Landi, L., Chiari, R., Delmonte, A., Morabito, A., Tamberi, S., Barbieri, F., Buosi, R., Gridelli, C., Tiseo, M., Gebbia, V., Fontanini, G., Crinò, L., Cappuzzo, F.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw332.07
Date:
September, 2016
File:
PDF, 65 KB
english, 2016
Conversion to is in progress
Conversion to is failed